New Key Statistics Module, Z-Score and F-Score
NAS:VRDN Key Ratios
| Market Cap $ M | 2,612.52 |
| Enterprise Value $ M | 1,971.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.41 |
| Price/Sales | 26.57 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 71.00 |
| EPS (TTM) $ | -3.37 |
| Beneish M-Score | 208.45 |
| 10-y EBITDA Growth Rate % | 34.40 |
| 5-y EBITDA Growth Rate % | 28.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.31 |
| EV-to-EBITDA | -5.32 |
| PEG | -- |
| Shares Outstanding M | 113.29 |
| Net Margin (%) | -544.06 |
| Operating Margin % | -569.68 |
| Pre-tax Margin (%) | -544.06 |
| Quick Ratio | 16.95 |
| Current Ratio | 16.95 |
| ROA % (ttm) | -49.04 |
| ROE % (ttm) | -63.68 |
| ROIC % (ttm) | -1,157.82 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.66 |
VRDN Number of Guru Trades
VRDN Volume of Guru Trades
Gurus Latest Trades with NAS:VRDN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRDN is held by these investors
Total 1
Viridian Therapeutics Inc Insider Transactions
No Available Data
News about NAS:VRDN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers